| GENMAB AS DK 1 |
| Dänemark |
| Gesundheit |
| DK0010272202 / 565131 |
| GE9 (Frankfurt) |
| FRA:GE9, ETR:GE9, GE9:GR |
| - |
| https://www.genmab.com/ |
|
Genmab A/S is a biotechnology company headquartered in Copenhagen, Denmark, specializing in the discovery and development of antibody-based therapeutics primarily for cancer and other serious diseases. Founded in 1998, it focuses on innovative human ..
>Volltext.. |
| 18827.2 Mio. EUR |
| 22140.44 Mio. EUR |
| 3585.87 Mio. EUR |
| 1239.51 Mio. EUR |
| 683.79 Mio. EUR |
| 11.12 EUR |
| 4671.86 Mio. EUR |
| 1331.65 Mio. EUR |
| 786.65 Mio. EUR |
| 1.32 |
| 14.12% |
| -42.16% |
| - |
| - |
| - |
| - |
| GENMAB |
| 04.10.26 |
|
||||
|